Nina N. Sykilinda

Dr. Nina N. Sykilinda


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2018 in Viruses
Verified
Journal Article
Open access
PDF file
NSNina N. Sykilinda
Nina N. Sykilinda
ANAlena Yurievna Nikolaeva
Alena Yurievna Nikolaeva
MSMikhail Shneider
Mikhail Shneider
DMDmitry V. Mishkin
Dmitry V. Mishkin
APArtem A. Patutin
Artem A. Patutin
KMKonstantin Miroshnikov
Konstantin Miroshnikov
Proteins that include enzymatic domain degrading the bacterial cell wall and a domain providing transport through the bacterial outer membrane are considered as prospective compounds to combat pathogenic Gram-negative bacteria. This paper presents an isolation and study of an enzyme of this class naturally encoded in the prophage region of Acinetobacter baumannii AB 5075 genome. Recombinant protein expressed in E. coli exhibits an antimicrobial activity with respect to live cultures of Gram-negative bacteria reducing the population of viable bacteria by 1.5–2 log colony forming units (CFU)/mL. However the protein becomes rapidly inactivated and enables the bacteria to restore the population. AcLys structure determined by X-ray crystallography reveals a predominantly α—helical fold similar to bacteriophage P22 lysozyme. The С-terminal part of AcLys polypeptide chains forms an α—helix enriched by Lys and Arg residues exposed outside of the protein globule. Presumably this type of structure of the C-terminal α—helix has evolved evolutionally enabling the endolysin to pass the inner membrane during the host lysis or, potentially, to penetrate the outer membrane of the Gram-negative bacteria.

Verified
Journal Article
Open access
PDF file
Peter V. EvseevPeter V. Evseev
Peter V. Evseev
ALAnna Lukianova
Anna Lukianova
NSNina N. Sykilinda
Nina N. Sykilinda
AGAnna Gorshkova
Anna Gorshkova
ABAlexander Bondar
Alexander Bondar
KMKonstantin Miroshnikov
Konstantin Miroshnikov
Pseudomonas phage MD8 is a temperate phage isolated from the freshwater lake Baikal. The organisation of the MD8 genome resembles the genomes of lambdoid bacteriophages. However, MD8 gene and protein sequences have little in common with classified representatives of lambda-like phages. Analysis of phage genomes revealed a group of other Pseudomonas phages related to phage MD8 and the genomic layout of MD8-like phages indicated extensive gene exchange involving even the most conservative proteins and leading to a high degree of genomic mosaicism. Multiple horizontal transfers and mosaicism of the genome of MD8, related phages and other λ-like phages raise questions about the principles of taxonomic classification of the representatives of this voluminous phage group. Comparison and analysis of various bioinformatic approaches applied to λ-like phage genomes demonstrated different efficiency and contradictory results in the estimation of genomic similarity and relatedness. However, we were able to make suggestions for the possible origin of the MD8 genome and the basic principles for the taxonomic classification of lambdoid phages. The group comprising 26 MD8-related phages was proposed to classify as two close genera belonging to a big family of λ-like phages.

27 February 2014 in Microbiology Resource Announcements
Verified
Journal Article
Open access
NSNina N. Sykilinda
Nina N. Sykilinda
ABAlexander Bondar
Alexander Bondar
AGAnna S. Gorshkova
Anna S. Gorshkova
LKLidia P. Kurochkina
Lidia P. Kurochkina
EKEugene Eugenyevich Kulikov
Eugene Eugenyevich Kulikov
KMKonstantin Miroshnikov
Konstantin Miroshnikov
The novel giant Pseudomonas aeruginosa bacteriophage PaBG was isolated from a water sample of the ultrafreshwater Lake Baikal. We report the complete genome sequence of this Myoviridae bacteriophage, comprising 258,139 bp of double-stranded DNA containing 308 predicted open reading frames.

3 July 2020 in Viruses
Verified
Journal Article
Open access
PDF file
Peter V. EvseevPeter V. Evseev
Peter V. Evseev
NSNina N. Sykilinda
Nina N. Sykilinda
AGAnna Gorshkova
Anna Gorshkova
LKLidia Kurochkina
Lidia Kurochkina
RZRustam Ziganshin
Rustam Ziganshin
KMKonstantin Miroshnikov
Konstantin Miroshnikov
Bacteriophage PaBG is a jumbo Myoviridae phage isolated from water of Lake Baikal. This phage has limited diffusion ability and thermal stability and infects a narrow range of Pseudomonas aeruginosa strains. Therefore, it is hardly suitable for phage therapy applications. However, the analysis of the genome of PaBG presents a number of insights into the evolutionary history of this phage and jumbo phages in general. We suggest that PaBG represents an ancient group distantly related to all known classified families of phages.

4 March 2025 in Viruses
Verified
Journal Article
Open access
PDF file
KTKonstantin Sergeevich Troshin
Konstantin Sergeevich Troshin
NSNina N. Sykilinda
Nina N. Sykilinda
SSSofia Shuraleva
Sofia Shuraleva
ATAnna Tokmakova
Anna Tokmakova
NTNikolay Andreevich Tkachenko
Nikolay Andreevich Tkachenko
Peter V. EvseevPeter V. Evseev
Peter V. Evseev
Phage Lydia, a newly isolated siphovirus infecting Pseudomonas aeruginosa, was characterized with respect to its basic kinetic properties and subjected to comparative bioinformatic analysis with related phages. The phage exhibited a restricted host range, with lytic activity observed against 7 of 30 tested isolates. The genome of phage Lydia consists of a 61,986 bp dsDNA molecule and contains 89 predicted genes. Bioinformatic analysis suggests the presence of a DNA modification system, but no apparent genes associated with lysogeny or antibiotic resistance were identified. Taxonomic classification places Lydia within the Mesyanzhinovviridae family, Rabinowitzvirinae subfamily, and Yuavirus genus, with the closest relation to Pseudomonas virus M6. Comprehensive bioinformatic studies, including structural modelling and analysis of phage proteins, as well as comparative taxonomic, phylogenomic, and pangenomic analyses of the Mesyanzhinovviridae family, revealed relationships between proteins of Mesyanzhinovviridae phages, proteins from other phage groups, encapsulins, and a gene transfer agent (GTA) particle from Rhodobacter capsulatus. These analyses uncovered patterns of evolutionary history within the family, characterized by genetic exchange events alongside the maintenance of a common genomic architecture, leading to the emergence of new groups within the family.

6 August 2025 in Viruses
Verified
Journal Article
Open access
PDF file
ACAndrei Viktorovich Chaplin
Andrei Viktorovich Chaplin
NSNina N. Sykilinda
Nina N. Sykilinda
GSGeorge Skvortsov
George Skvortsov
KTKonstantin Sergeevich Troshin
Konstantin Sergeevich Troshin
AVAnna A. Vasilyeva
Anna A. Vasilyeva
Peter V. EvseevPeter V. Evseev
Peter V. Evseev
Antibiotic-resistant Pseudomonas aeruginosa presents a critical global health challenge, particularly in hospital-acquired infections. Bacteriophages offer a promising therapeutic avenue due to their ability to target and lyse resistant strains. This study characterizes Pseudomonas phage Banzai, a newly isolated Pbunavirus (family Lindbergviridae) with lytic activity against multiple P. aeruginosa isolates, including multidrug-resistant strains. Genomic analysis revealed a 66,189 bp genome, lacking antibiotic resistance or virulence factors, and suggested a headful packaging mechanism and the presence of a bidirectional component in the replication. In vivo experiments using Galleria mellonella showed therapeutic potential, significantly improving larval survival (87% at 24 h). Host range analysis revealed activity against 13 of 30 P. aeruginosa isolates, including members of O1, O3, O5 and O6 in silico predicted serogroups. Phylogenomic analyses place phage Banzai within the genus Pbunavirus, sharing 94.8% intergenomic similarity with its closest relatives, supporting its classification as a novel species. These findings highlight phage Banzai as a potential candidate for phage therapy, demonstrating genomic stability, a strictly lytic lifestyle, and in vivo efficacy.